Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2013-04-04

FDA Approved: GONAL-F — Supplemental Application (EMD Serono, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for GONAL-F (follitropin alfa) from EMD Serono, Inc., resulting in changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gonal-F (follitropin alfa)

Snippet

SUPPL AP for GONAL-F (FOLLITROPIN ALFA)